|
|
|
| Clinical application of protein hydrolysate multi-nutrient powder in esophageal cancer postoperative patients |
| 1Department of the Thoracic Surgery, the People’s Hospital of Taizhou, Taizhou 225300, Jiangsu, China; 2Department of Clinical Nutrition, the People’s Hospital of Taizhou, Taizhou 225300, Jiangsu, China |
|
|
|
|
Abstract Objective To investigate the clinical application value of protein hydrolysate multi-nutrient powder in esophageal cancer postoperative patients. Methods Sixty esophageal cancer postoperative patients were divided into the experimental group and the control group, 30 cases in each group. The experimental group received routine nutritional therapy, while protein hydrolysate multi-nutrient powder was administered orally or tube-fed, and the control group received routine nutritional therapy for a total of seven days. The time of initial exhaust, the relevant nutritional indicators and the incidence of abdominal diarrhea etc on the third day and the seventh day were observed and compared respectively, the differences between the two groups were significant differences (P<0.05). Results After the nutritional therapy, the time of initial exhaust of the patients in the experimental group was significantly earlier [in the experimental group: (56.01±8.88)h, in the control group: (62.52±7.63)h; P=0.00)], the incidence of abdominal diarrhea was significantly lower than that of the control group, the differences were statistically significant. The incidence of nausea and vomiting was with no difference of the control group. The two groups of patients related to nutritional indicators had different degrees of improvement trend. The levels of prealbumin were significantly higher in the experimental group than that in the control group, the differences were statistically significant, but the serum total protein and albumin and transferrin between the two groups were with no statistical differences. Conclusions protein hydrolysate multi-nutrient powder can effectively improve the negative nitrogen balance, promote gastrointestinal function recovery, with good gastrointestinal tolerance. It is of guiding significance to the clinical treatment of postoperative patients with esophageal cancer.
|
|
|
|
|
|
| [1] |
1FAN Yue-ping， 2ZHANG Tian， 2QU Qian-nuo， 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
| [2] |
ZHAO Xiang，WANG Wen-jing. ONS improves nutritional status of esophageal cancer patients under radiotherapy treatment[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 357-360. |
| [3] |
1XUE Tao， 1WANG Wei-hong， 2MA Hui，1ZHANG Na，1ZHANG Sheng-Jun， 1DU Xin-ying . Application of perioperative nutritional support in patients with meningioma[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 326-331. |
| [4] |
CHENG Guo-wei， SUN Li， CHEN Ping， HE Xiang-ling， SU Dan， XI Heng-zhi， ZANG Ding-qi. Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 332-336. |
| [5] |
1*LUO Min， 2*WU Xiao-jun， 2ZHANG Xin， 3DONG Guang， 4XIONG Li-long， 4WANG Peng-cheng， 1GAO Kui， 1YU Ping， 1HE Mei， 5DU Chi， 5JIANG Ou， 6SHI Han-ping . ABD bioactives alleviates chemotherapy-induced myelosuppression[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 346-350. |
| [6] |
ZHANG Chong， CAO Long-xiang， LV Ying-ying， WANG Ying， WANG Lu-ming， LV Wang， HU Jian. Clinical application and research of abdominal retrograde gastric and jejunal feeding tube[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 206-211. |
|
|
|
|
